A Study of Letrozole in the Treatment of Endometrial Cancer

Clinical trial NCT00333086 · COMPLETED

Trial details

NCT number: NCT00333086
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent and Metastatic Endometrial Cancer

Start date: 2000-01-01
Primary completion: 2006-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.